236 related articles for article (PubMed ID: 22764846)
1. A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders.
Lyckholm L; Heddinger SP; Parker G; Coyne PJ; Ramakrishnan V; Smith TJ; Henkin RI
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):111-4. PubMed ID: 22764846
[TBL] [Abstract][Full Text] [Related]
2. A double blind study of the effects of zinc sulfate on taste and smell dysfunction.
Henkin RI; Schecter PJ; Friedewald WT; Demets DL; Raff M
Am J Med Sci; 1976; 272(3):285-99. PubMed ID: 797259
[TBL] [Abstract][Full Text] [Related]
3. Taste and smell alterations in cancer patients--real problems with few solutions.
Halyard MY
J Support Oncol; 2009; 7(2):68-9. PubMed ID: 19408460
[No Abstract] [Full Text] [Related]
4. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation.
Ripamonti C; Zecca E; Brunelli C; Fulfaro F; Villa S; Balzarini A; Bombardieri E; De Conno F
Cancer; 1998 May; 82(10):1938-45. PubMed ID: 9587128
[TBL] [Abstract][Full Text] [Related]
5. Smell and Taste Disorders Resulting from Cancer and Chemotherapy.
Cohen J; Wakefield CE; Laing DG
Curr Pharm Des; 2016; 22(15):2253-63. PubMed ID: 26881441
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of exogenous oral zinc in treatment of patients with carbonic anhydrase VI deficiency.
Henkin RI; Martin BM; Agarwal RP
Am J Med Sci; 1999 Dec; 318(6):392-405. PubMed ID: 10616164
[TBL] [Abstract][Full Text] [Related]
7. Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients.
Schiffman SS; Sattely-Miller EA; Taylor EL; Graham BG; Landerman LR; Zervakis J; Campagna LK; Cohen HJ; Blackwell S; Garst JL
J Nutr Health Aging; 2007; 11(5):439-54. PubMed ID: 17657366
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy alters subjective senses of taste and smell but not dietary patterns in Japanese lung cancer patients.
Yoshimoto N; Inagaki M; Sekiguchi Y; Tomishima Y; Masuko K
Support Care Cancer; 2020 Apr; 28(4):1667-1674. PubMed ID: 31286236
[TBL] [Abstract][Full Text] [Related]
9. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
Halyard MY; Jatoi A; Sloan JA; Bearden JD; Vora SA; Atherton PJ; Perez EA; Soori G; Zalduendo AC; Zhu A; Stella PJ; Loprinzi CL
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1318-22. PubMed ID: 17394940
[TBL] [Abstract][Full Text] [Related]
10. Ineffectiveness of zinc in treating ordinary taste and smell dysfunctions.
Nutr Rev; 1979 Sep; 37(9):283-5. PubMed ID: 394044
[No Abstract] [Full Text] [Related]
11. Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge.
Comeau TB; Epstein JB; Migas C
Support Care Cancer; 2001 Nov; 9(8):575-80. PubMed ID: 11762967
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin supplementation for taste and smell abnormalities among patients receiving cancer chemotherapy.
Lesser GJ; Irby MB; Taylor RC; Snavely A; Case D; Wang A; Dietrich A; Duncan S
Support Care Cancer; 2022 Mar; 30(3):2017-2025. PubMed ID: 34642792
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced taste and smell changes influence food perception in cancer patients.
Drareni K; Bensafi M; Giboreau A; Dougkas A
Support Care Cancer; 2021 Apr; 29(4):2125-2132. PubMed ID: 32870414
[TBL] [Abstract][Full Text] [Related]
14. Taste and smell disturbances in cancer patients: a scoping review of available treatments.
Sevryugin O; Kasvis P; Vigano M; Vigano A
Support Care Cancer; 2021 Jan; 29(1):49-66. PubMed ID: 32734392
[TBL] [Abstract][Full Text] [Related]
15. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer.
Hutton JL; Baracos VE; Wismer WV
J Pain Symptom Manage; 2007 Feb; 33(2):156-65. PubMed ID: 17280921
[TBL] [Abstract][Full Text] [Related]
16. Treatments for smell and taste disorders: A critical review.
Doty RL
Handb Clin Neurol; 2019; 164():455-479. PubMed ID: 31604562
[TBL] [Abstract][Full Text] [Related]
17. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation.
Epstein JB; Phillips N; Parry J; Epstein MS; Nevill T; Stevenson-Moore P
Bone Marrow Transplant; 2002 Dec; 30(11):785-92. PubMed ID: 12439702
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.
Henkin RI
Drug Saf; 1994 Nov; 11(5):318-77. PubMed ID: 7873092
[TBL] [Abstract][Full Text] [Related]
19. Clinical physiology of taste and smell.
Schiffman SS; Gatlin CA
Annu Rev Nutr; 1993; 13():405-36. PubMed ID: 8369152
[No Abstract] [Full Text] [Related]
20. Taste alterations and cancer treatment.
van Oort S; Kramer E; de Groot JW; Visser O
Curr Opin Support Palliat Care; 2018 Jun; 12(2):162-167. PubMed ID: 29570496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
